Using hybrid GA-ANN to predict biological activity of HIV protease inhibitors (original) (raw)
An Integrated Soft Computing Approach for Predicting Biological Activity of Potential HIV-1 Protease Inhibitors
Razvan Andonie
The 2006 IEEE International Joint Conference on Neural Network Proceedings, 2006
View PDFchevron_right
Hybrid-genetic algorithm based descriptor optimization and QSAR models for predicting the biological activity of Tipranavir analogs for HIV protease inhibition
sunil kumar
Journal of Molecular Graphics and Modelling, 2010
View PDFchevron_right
QSAR models for prediction study of HIV protease inhibitors using support vector machines, neural networks and multiple linear regression
BRAHIM MINAOUI
Arabian Journal of Chemistry, 2017
View PDFchevron_right
A quantitative structure–activity relationship study on HIV-1 integrase inhibitors using genetic algorithm, artificial neural networks and different statistical methods
SHAHAB SHARIATI
Arabian Journal of Chemistry, 2016
View PDFchevron_right
Evaluation of potential HIV-1 reverse transcriptase inhibitors by artificial neural networks
Vsevolod Tanchuk
Proceedings of IEEE Symposium on Computer-Based Medical Systems (CBMS)
View PDFchevron_right
Neural Networks :Application for prediction of Anti-HIV-1 Activity of HEPT Derivatives
Didier Villemin
View PDFchevron_right
Pattern recognition: Application of Support Vector Machines, Artificial Neural Networks and Decision Trees for anti-HIV activity prediction of organic compounds
Didier Villemin
2011 International Conference on Multimedia Computing and Systems, 2011
View PDFchevron_right
Classification of anti-HIV compounds using counterpropagation artificial neural networks and decision trees
Mohsen Mahmoodi
SAR and QSAR in Environmental Research, 2011
View PDFchevron_right
Artificial neural network model for predicting HIV protease cleavage sites in protein
Abdullah Al-Badi
Advances in Engineering Software, 1998
View PDFchevron_right
Feature Selection Using a Genetic Algorithms and Fuzzy logic in Anti- Human Immunodeficiency Virus Prediction for Drug Discovery
houda Labjar
2021
View PDFchevron_right
ANN-based Drug-isolate-fold-change model predicting the resistance profiles of HIV-1 protease inhibitors
hüseyin tunç
2022
View PDFchevron_right
Neural Network and Bioinformatic Methods for Predicting HIV-1 Protease Inhibitor Resistance
Gail Carpenter
CAS/CNS Technical Report Series, 2010
View PDFchevron_right
Artificial neural networks: Non-linear QSAR studies of HEPT derivatives as HIV-1 reverse transcriptase inhibitors
Abdelmajid Zyad
Molecular Diversity, 2004
View PDFchevron_right
Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones
Kunal Roy
Journal of Enzyme Inhibition and Medicinal Chemistry, 2008
View PDFchevron_right
A structure-motivated hybrid machine for prediction of biological activity of chemical compounds
amit kumar mishra
2010
View PDFchevron_right
HIVprotI: an integrated web based platform for prediction and design of HIV proteins inhibitors
Abid Qureshi
Journal of cheminformatics, 2018
View PDFchevron_right
A hybrid decision trees-adaptive neuro-fuzzy inference system in prediction of anti-HIV molecules
Mohammed RAMDANI
Expert Systems with Applications, 2011
View PDFchevron_right
Genetic algorithm optimization in drug design QSAR: Bayesian-regularized genetic neural networks (BRGNN) and genetic algorithm-optimized support vectors machines (GA-SVM)
Julio Caballero
Molecular Diversity, 2011
View PDFchevron_right
Prediction of HIV-1 protease resistance using genotypic, phenotypic, and molecular information with artificial neural networks
berna dogan
PeerJ
View PDFchevron_right
Predicting HIV drug resistance with neural networks
Sorin Draghici
Bioinformatics, 2003
View PDFchevron_right
Analysis of Resistance to Human Immunodeficiency Virus Protease Inhibitors Using Molecular Mechanics and Machine Learning Strategies
alex anand, Dr. HARISHCHANDER ANANDARAM
View PDFchevron_right
Why neural networks should not be used for HIV1 protease cleavage site prediction
Thorsteinn Rögnvaldsson
Bioinformatics/computer Applications in The Biosciences, 2004
View PDFchevron_right
Support vector machines: Development of QSAR models for predicting anti-HIV-1 activity of TIBO derivatives
Didier Villemin
European Journal of Medicinal Chemistry, 2010
View PDFchevron_right
An automated workflow by using KNIME Analytical Platform: a case study for modelling and predicting HIV-1 protease inhibitors
Sila Kittiwachana
Progress in Drug Discovery & Biomedical Science, 2019
View PDFchevron_right